Share of people with HIV who receive antiretroviral therapy in Djibouti
Djibouti: Share of people with HIV who receive antiretroviral therapy was 25.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Djibouti, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
Djibouti recorded 25.0% for share of people with hiv who receive antiretroviral therapy in 2024.
The figure is down 3.8% on the previous year and up 108.3% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Djibouti peaked at 26.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Djibouti 139th out of 143 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Djibouti, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 2.0% | +100.0% |
| 2006 | 3.0% | +50.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 5.0% | +25.0% |
| 2009 | 6.0% | +20.0% |
| 2010 | 6.0% | +0.0% |
| 2011 | 7.0% | +16.7% |
| 2012 | 9.0% | +28.6% |
| 2013 | 10.0% | +11.1% |
| 2014 | 12.0% | +20.0% |
| 2015 | 16.0% | +33.3% |
| 2016 | 19.0% | +18.8% |
| 2017 | 22.0% | +15.8% |
| 2018 | 25.0% | +13.6% |
| 2019 | 19.0% | -24.0% |
| 2020 | 21.0% | +10.5% |
| 2021 | 20.0% | -4.8% |
| 2022 | 22.0% | +10.0% |
| 2023 | 26.0% | +18.2% |
| 2024 | 25.0% | -3.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.1% | 0.0% | 6.0% | 10 |
| 2010s | 14.5% | 6.0% | 25.0% | 10 |
| 2020s | 22.8% | 20.0% | 26.0% | 5 |
Countries ranked near Djibouti
More health data for Djibouti
- Un projection of annual infant deaths, annual growth rate -1.5 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2173 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,107 deaths per 1,000 people (2090)
- Number of infants who die before age 1 197 deaths (2100)
- Population ages 30-34, female, annual growth rate 1.2 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0392 units per person (2025)
- Population ages 30-34, male, annual growth rate 1.18 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0389 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Djibouti?
- Share of people with hiv who receive antiretroviral therapy in Djibouti was 25.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Djibouti?
- The highest recorded value was 26.0% in 2023.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Djibouti?
- The lowest recorded value was 0.0% in 2000.
- How does Djibouti rank for share of people with hiv who receive antiretroviral therapy?
- Djibouti ranks 139th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Djibouti?
- Over the last ten years it is up 108.3%. The long-run trend across the full record is volatile.
- Where does this Djibouti data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.